These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35675139)

  • 61. Oestrogen-related tumour phenotype: positron emission tomography characterisation with ¹⁸F-FDG and ¹⁸F-FES.
    Tsujikawa T; Yoshida Y; Maeda H; Tsuchida T; Mori T; Kiyono Y; Kimura H; Okazawa H
    Br J Radiol; 2012 Jul; 85(1015):1020-4. PubMed ID: 22337690
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Simultaneous breast cancer and DLBCL lymphoma - role of PET/CT examination with 18F-FDG and 18F-FES.
    Hołody Ł; Kunikowska J; Braziewicz J
    Nucl Med Rev Cent East Eur; 2018; 21(2):113-114. PubMed ID: 29956818
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Molecular Imaging for Estrogen Receptor-Positive Breast Cancer: Clinical Applications of Whole Body and Dedicated Breast Positron Emission Tomography.
    Goodman K; Abel MK; Lawhn-Heath C; Molina-Vega J; Jones EF; Mukhtar RA
    Surg Oncol Clin N Am; 2022 Oct; 31(4):569-579. PubMed ID: 36243494
    [No Abstract]   [Full Text] [Related]  

  • 64. Comparative breast tumor imaging and comparative in vitro metabolism of 16alpha-[18F]fluoroestradiol-17beta and 16beta-[18F]fluoromoxestrol in isolated hepatocytes.
    Jonson SD; Bonasera TA; Dehdashti F; Cristel ME; Katzenellenbogen JA; Welch MJ
    Nucl Med Biol; 1999 Jan; 26(1):123-30. PubMed ID: 10096512
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer.
    Dehdashti F; Mortimer JE; Trinkaus K; Naughton MJ; Ellis M; Katzenellenbogen JA; Welch MJ; Siegel BA
    Breast Cancer Res Treat; 2009 Feb; 113(3):509-17. PubMed ID: 18327670
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prognostic Value of 16α-
    Yamada S; Tsuyoshi H; Yamamoto M; Tsujikawa T; Kiyono Y; Okazawa H; Yoshida Y
    J Nucl Med; 2021 May; 62(5):636-642. PubMed ID: 33008930
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
    J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnostic accuracy and safety of 16α-[
    Chae SY; Ahn SH; Kim SB; Han S; Lee SH; Oh SJ; Lee SJ; Kim HJ; Ko BS; Lee JW; Son BH; Kim J; Ahn JH; Jung KH; Kim JE; Kim SY; Choi WJ; Shin HJ; Gong G; Lee HS; Lee JB; Moon DH
    Lancet Oncol; 2019 Apr; 20(4):546-555. PubMed ID: 30846327
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnostic imaging using positron emission tomography for gynecological malignancy.
    Tsuyoshi H; Yoshida Y
    J Obstet Gynaecol Res; 2017 Nov; 43(11):1687-1699. PubMed ID: 28884883
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discrepancy between [18F]-FES and [18F]-FDG PET/CT in ER-positive breast cancer with oesophageal metastasis.
    Kiatkittikul P; Promteangtrong C; Kunawudhi A; Siripongsatian D; Chotipanich C
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3297-3298. PubMed ID: 35362795
    [No Abstract]   [Full Text] [Related]  

  • 71. In vivo imaging of brain estrogen receptors in rats: a 16α-18F-fluoro-17β-estradiol PET study.
    Khayum MA; de Vries EF; Glaudemans AW; Dierckx RA; Doorduin J
    J Nucl Med; 2014 Mar; 55(3):481-7. PubMed ID: 24481026
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of diagnostic sensitivity of [
    Chae SY; Son HJ; Lee DY; Shin E; Oh JS; Seo SY; Baek S; Kim JY; Na SJ; Moon DH
    EJNMMI Res; 2020 May; 10(1):54. PubMed ID: 32448947
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 18F-Fluoroestradiol PET in the evaluation of probable oligometastatic breast cancer.
    Denton M; Taubman K; Sutherland T
    J Med Imaging Radiat Oncol; 2021 Jun; 65(3):333-334. PubMed ID: 33369181
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 18F-Fluoroestradiol PET/CT Correctly Diagnosed 18F-FDG-Avid Inflammatory Lymph Nodes in a Patient With Estrogen Receptor-Positive Breast Cancer.
    Yamane T; Ueda S; Seto A; Kuji I
    Clin Nucl Med; 2018 May; 43(5):379-380. PubMed ID: 29485433
    [TBL] [Abstract][Full Text] [Related]  

  • 75. PET in breast cancer.
    Flanagan FL; Dehdashti F; Siegel BA
    Semin Nucl Med; 1998 Oct; 28(4):290-302. PubMed ID: 9800236
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    Paquette M; Espinosa-Bentancourt E; Lavallée É; Phoenix S; Lapointe-Milot K; Bessette P; Guérin B; Turcotte ÉE
    J Nucl Med; 2022 May; 63(5):702-707. PubMed ID: 34413142
    [TBL] [Abstract][Full Text] [Related]  

  • 77. FDG-PET Assessment of Other Gynecologic Cancers.
    Faria S; Devine C; Viswanathan C; Javadi S; Korivi BR; Bhosale PR
    PET Clin; 2018 Apr; 13(2):203-223. PubMed ID: 29482750
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
    Signorelli M; Guerra L; Buda A; Picchio M; Mangili G; Dell'Anna T; Sironi S; Messa C
    Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Detection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease.
    Ryu SY; Kim K; Kim Y; Park SI; Kim BJ; Kim MH; Choi SC; Lee ED; Lee KH; Kim BI
    J Korean Med Sci; 2010 Jul; 25(7):1029-33. PubMed ID: 20592894
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples.
    Morgat C; Schollhammer R; Macgrogan G; Barthe N; Vélasco V; Vimont D; Cazeau AL; Fernandez P; Hindié E
    PLoS One; 2019; 14(1):e0210905. PubMed ID: 30645633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.